🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Managements for refractory proficient mismatch repair (pMMR) or microsatell...
Status
Completed
Location
Hunan Cancer hospital
Start Date
2019-07-01
Trial ID
NCT05942768
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
This is a single arm, nonrandomized, single center clinical study to invest...
Status
Unknown
Location
Hai-Tao Zhao
Start Date
2021-10-01
Trial ID
NCT05048017
Treatments Being Tested
The investigators propose to conduct a single-center, single-arm, Phase I c...
Status
Active Not Recruiting
Location
Colorectal Cancer, West China Hospital
Start Date
2025-02-21
Trial ID
NCT06865521
Treatments Being Tested
This is a multicenter observational study aimed to describe the efficacy an...
Status
Unknown
Location
Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2019-05-01
Trial ID
NCT04771715
Treatments Being Tested
To determine if the regorafenib and nivolumab combination (RegoNivo) improv...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2021-05-05
Trial ID
NCT04879368
Treatments Being Tested
There is no definitive evidence regarding the therapeutic efficacy of PD-1 ...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2020-01-01
Trial ID
NCT07537985
Treatments Being Tested
The study is an interventional phase II clinical trial aiming to evaluate t...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2023-10-25
Trial ID
NCT06099821
Treatments Being Tested
This study is intended to evaluate efficacy and safety of the combination o...
Status
Unknown
Location
Department of Medical Oncology, Shanghai Changzheng Hospital
Start Date
2019-03-01
Trial ID
NCT04110093
Treatments Being Tested
The efficacy of combining TKI with PD-1 inhibitor in the treatment of advan...
Status
Recruiting
Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2023-12-01
Trial ID
NCT06543836
Treatments Being Tested